168 related articles for article (PubMed ID: 27659535)
41. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
[TBL] [Abstract][Full Text] [Related]
42. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.
Wang-Johanning F; Gillespie GY; Grim J; Rancourt C; Alvarez RD; Siegal GP; Curiel DT
Cancer Res; 1998 May; 58(9):1893-900. PubMed ID: 9581830
[TBL] [Abstract][Full Text] [Related]
43. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
[TBL] [Abstract][Full Text] [Related]
44. [Expression of HPV16 E7 protein and preparation of its polyclonal antibody].
Wang B; Tu J; Lv Y; Hou B; Liu Q; Lin X; Chen S; Xue X; Zhu S; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):167-70. PubMed ID: 24491058
[TBL] [Abstract][Full Text] [Related]
45. Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix.
Ramirez N; Guerra F; Camporeale G; Quintana S; Diaz LB; Cuneo N; Villacorta Hidalgo J; Tatti SA; Alonso LG; Borkosky SS; Prat Gay G; Palaoro L
Biotech Histochem; 2015; 90(8):573-80. PubMed ID: 26052817
[TBL] [Abstract][Full Text] [Related]
46. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
47. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo.
Wang W; Sima N; Kong D; Luo A; Gao Q; Liao S; Li W; Han L; Wang J; Wang S; Lu Y; Wang D; Xu G; Zhou J; Meng L; Ma D
Cancer Lett; 2010 May; 291(1):67-75. PubMed ID: 19903581
[TBL] [Abstract][Full Text] [Related]
48. Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV-16 E7 oncoprotein.
Nauenburg S; Zwerschke W; Jansen-Durr P
FASEB J; 2001 Mar; 15(3):592-4. PubMed ID: 11259377
[TBL] [Abstract][Full Text] [Related]
49. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
51. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
52. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
53. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
54. A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.
Granadillo M; Vallespi MG; Batte A; Mendoza O; Soria Y; Lugo VM; Torrens I
Vaccine; 2011 Jan; 29(5):920-30. PubMed ID: 21145912
[TBL] [Abstract][Full Text] [Related]
55. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.
Accardi L; Paolini F; Mandarino A; Percario Z; Di Bonito P; Di Carlo V; Affabris E; Giorgi C; Amici C; Venuti A
Int J Cancer; 2014 Jun; 134(11):2742-7. PubMed ID: 24226851
[TBL] [Abstract][Full Text] [Related]
56. Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.
Rahma OE; Herrin VE; Ibrahim RA; Toubaji A; Bernstein S; Dakheel O; Steinberg SM; Abu Eid R; Mkrtichyan M; Berzofsky JA; Khleif SN
J Transl Med; 2014 Dec; 12():353. PubMed ID: 25510844
[TBL] [Abstract][Full Text] [Related]
57. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
58. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
59. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
60. Engineered Salmonella typhimurium expressing E7 fusion protein, derived from human papillomavirus, inhibits tumor growth in cervical tumor-bearing mice.
Yoon W; Choi JH; Kim S; Park YK
Biotechnol Lett; 2014 Feb; 36(2):349-56. PubMed ID: 24146199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
